862992-93-6 Usage
Uses
Used in Organic Synthesis:
2-(benzyloxy)-3-bromobenzonitrile is utilized as a key building block in the synthesis of various pharmaceuticals, agrochemicals, and other fine chemicals. Its unique structure allows for the creation of a wide range of compounds with potential applications in different industries.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-(benzyloxy)-3-bromobenzonitrile is employed as a versatile intermediate for the development of new drugs. Its chemical properties enable the formation of diverse molecular structures, which can be further modified to target specific therapeutic areas.
Used in Agrochemical Development:
2-(benzyloxy)-3-bromobenzonitrile is also used in the agrochemical sector as a starting material for the synthesis of various crop protection agents. Its reactivity and structural features make it suitable for the creation of compounds with potential pesticidal or herbicidal properties.
It is important to handle 2-(benzyloxy)-3-bromobenzonitrile with care due to its potential health hazards and environmental impact. Proper safety measures should be taken to minimize risks associated with its use in research and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 862992-93-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,2,9,9 and 2 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 862992-93:
(8*8)+(7*6)+(6*2)+(5*9)+(4*9)+(3*2)+(2*9)+(1*3)=226
226 % 10 = 6
So 862992-93-6 is a valid CAS Registry Number.
862992-93-6Relevant academic research and scientific papers
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
-
Page/Page column 5; 12, (2009/04/24)
The invention provides 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds of formula (I): wherein R2, R7, and m are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are antagonists at the mu opioid receptor. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat conditions associated with mu opioid receptor activity, and processes and intermediates useful for preparing such compounds.
CALCILYTIC COMPOUNDS
-
Page/Page column 17, (2010/02/13)
Novel calcilytic compounds and methods of using them are provided.
